JD Health International's (HKG:6618) attributable profit rose to 3.44 billion yuan in the first half from 2.60 billion yuan in the year-ago period, according to a Thursday filing with the Hong Kong bourse
Earnings per share at the pharmaceutical and healthcare products company increased to 1.07 yuan from 0.81 yuan in the prior-year period.
Revenue grew 16% year over year to 40.9 billion yuan from 35.3 billion yuan.